Treatment of Erectile Dysfunction in Type 2 Diabetic Men
Journal Title: Міжнародний ендокринологічний журнал - Year 2015, Vol 8, Issue 72
Abstract
Background. One of the most frequent complications of diabetes in men is erectile dysfunction. Phosphodiesterase-5 inhibitors (IPDE-5): sildenafil, vardenafil and tadalafil are the drugs of choice for the treatment of erectile dysfunction. Objective. To study the effectiveness and safety of treatment of erectile dysfunction with inhibitor of phosphodiesterase 5 in type 2 diabetic men. Material and methods. The study involved 89 men aged 39–69 years old. Рatients with type 2 diabetes mellitus and erectile dysfunction with diabetes duration of 1–12 years were examined in a state of diabetes mellitus compensation (average glycated hemoglobin 7.3 ± 1.1 %). Sildenafil 100 mg on demand before coitus during 12 weeks led to the significant growth rate of domain of «Erectile function» on 10.54 score. Sildenafil was effective in 76.2 % of patients. Increment of such parameter as erectile function during tadalafil treatment was 9.81 scores. Efficacy of tadalafil was 73.1 %. Application of vardenafil led to the improvement of erectile function to an average of 25.22 ± 1.80 scores. Efficacy of vardenafil in our patients was 76.2 %. Conclusions. The study confirmed the high efficiency of three IPDE-5 as the first-line drugs for the treatment of erectile dysfunction in men with diabetes. All three drugs were used in maximum doses, as lower doses are not always effective enough. All patients with reduced blood levels of total testosterone should receive replacement therapy to achieve levels of testosterone within the normal hormone fluctuations. Further study of the effects IPDE-5 in type 2 diabetic men are necessary to improve their effectiveness.
Authors and Affiliations
V. Ye. Luchytskyi
Keywords
Related Articles
- EP ID EP215638
- DOI -
- Views 35
- Downloads 0
Treatment with Glucagon-Like Peptide-1 Analogues — a Breakthrough in Diabetes Mellitus Type 2 Therapy
The paper analyzes the data of modern scientific literature on the new class of drugs that restore the effect of glucagon-like peptide-1 (GLP-1). According to modern concepts, the pathophysio-logical mechanisms of therap...
Subclinical Hypercorticism: the Necessity of Diagnostic Search
Considering certain difficulties in subclinical hypercorticism diagnosis, the object of this work is to focus attention of doctors in different areas on the necessity of thorough examination of patients with pathological...
Features of Treatment of Patients with Diabetes Mellitus Type 2 with Heart Failure (Literature Review)
Diabetes mellitus and heart failure are often comorbid conditions. The studies found that patients taking metformin as monotherapy (odds ratio 0.65 (0.48–0.87)) or in conjunction with other drugs (0.72 (0.59–0.90)), mort...
Role of Training System in the Formation of Active Motivation to Self-Management in Patients with Diabetes Mellitus
The article presents research data confirming the importance of self-management training to achieve and maintain long-term compensation in patients with diabetes mellitus. There are provided an analysis of the literature...
Clinical Case of the Combined Course of Diffuse Toxic Goiter and Autoimmune Ophthalmopathy
The article presents the experience of treating a patient with diffuse toxic goiter in conjunction with autoimmune ophthalmopathy, about what the patient took thyrostatic drugs, β-blockers, systemic glucocorticoids. On t...